📰 Development Cloud News
Page 7 - Development Cloud News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Development Cloud. Real-time updates on events, politics, business and more.
June 30, 2022
Alibaba is set to utilize its huge swarths of data for its latest enterprise intelligence venture.
June 1, 2022
/PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results...
March 29, 2022
/PRNewswire/ -- Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheims selection of Veeva Development Cloud to drive...
March 29, 2022
With Veeva Development Cloud, Boehringer Ingelheim aims to establish a connected technology landscape for agile collaboration that can accelerate the development of novel medicines Transformation
January 20, 2022
European research association establishing technology foundation for greater efficiency and speed across research projects BARCELONA, Spain, Jan. 20, 2022 /PRNewswire/ -- Veeva Systems
January 20, 2022
PLEASANTON, Calif., Jan. 20, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that the Lymphoma Academic Research Organization (LYSARC) selected...
January 20, 2022
PLEASANTON, Calif., Jan. 20, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that the Lymphoma Academic Research Organization (LYSARC) selected...
December 2, 2021
VEEV earnings call for the period ending September 30, 2021.
May 28, 2021
VEEV earnings call for the period ending March 31, 2021.
May 19, 2021
Veeva Development Cloud Streamlining Drug Development Industrywide Unified application suites for clinical, regulatory, quality, and safety eliminate siloes to increase efficiency and improve compliance News provided by Share this article Share this article PLEASANTON, Calif., May 19, 2021 /PRNewswire/ -- A growing number of life sciences companies are adopting Veeva Development Cloud applications from Veeva Systems (NYSE: VEEV) in an industrywide shift to streamline drug development. More than...